FirstView Insight is a global market research and business consulting firm which focuses exclusively on healthcare domain. We help pharmaceutical companies to turn out to be progressively focused in a rapidly evolving market characterized by unpredictable product pipelines and uncertain regulatory actions. We advise healthcare companies in developing strategies that win through a relentless focus on capturing important information which assists the clients in decision making and to address new challenges in a fast-paced healthcare environment.
FirstView Insight help clients to realize their products value through specialty practices in Research & development, Competitive Intelligence, Pipeline Intelligence, Clinical Trial analysis, Mergers and Collaborations, Launch Timeline Analysis, Pricing & Market Access and HEOR. The company helps to provide credible, detailed information on opportunities and threat to the client making sure you maximize value at each stage.
Publications found:
142
Sort by:
4 - 1BB Receptor Agonist - Pipeline Review - 2019
US$ 1,250.00
Firstview Market Insight '4-1BB receptor Agonist - Pipeline Review-2019' provides an overview of the pipeline landscape for 4-1BB receptor Agonist - Pipeline Review-2019. It provides comprehensive ins...
November 2019
90 pages
Acute Lymphoblastic Leukemia - Pipeline Review, 2019
US$ 1,250.00
Firstview Insight's Acute Lymphoblastic Leukemia - Pipeline Review, 2019 provides an overview of the pipeline landscape of Acute Lymphoblastic Leukemia It provides comprehensive insights of all the cl...
November 2019
165 pages
Acute Myeloid Leukemia - Pipeline Review, 2019
US$ 1,400.00
Firstview Insight's Acute Myeloid Leukemia - Pipeline Review, 2019 provides an overview of the pipeline landscape of Acute Myeloid Leukemia It provides comprehensive insights of all the clinical and n...
November 2019
180 pages
Age related macular degeneration - Pipeline Review, 2019
US$ 1,250.00
Firstview Insight's Age related macular degeneration - Pipeline Review, 2019 provides an overview of the pipeline landscape of Age related macular degenerationIt provides comprehensive insights of all...
November 2019
150 pages
Allergic Conjunctivitis - Pipeline Review, 2019
US$ 1,250.00
Firstview Insight's Allergic Conjunctivitis - Pipeline Review, 2019 provides an overview of the pipeline landscape of Allergic Conjunctivitis It provides comprehensive insights of all the clinical and...
November 2019
150 pages
Alopecia Areata - Pipeline Review, 2019
US$ 1,250.00
Firstview Insight's Alopecia Areata - Pipeline Review, 2019 provides an overview of the pipeline landscape of Alopecia AreataIt provides comprehensive insights of all the clinical and non-clinical the...
November 2019
150 pages
Alpha Antitrypsin Deficiency - Pipeline Review, 2019
US$ 1,250.00
Firstview Insight's Alpha Antitrypsin Deficiency - Pipeline Review, 2019 provides an overview of the pipeline landscape of Alpha Antitrypsin Deficiency It provides comprehensive insights of all the cl...
November 2019
150 pages
Alpha Thalassemia - Pipeline Review, 2019
US$ 1,250.00
Firstview Insight's Alpha Thalassemia - Pipeline Review, 2019 provides an overview of the pipeline landscape of Alpha Thalassemia It provides comprehensive insights of all the clinical and non-clinica...
November 2019
150 pages
Amyloidosis - Pipeline Review, 2019
US$ 1,250.00
Firstview Insight's Amyloidosis - Pipeline Review, 2019 provides an overview of the pipeline landscape of Amyloidosis It provides comprehensive insights of all the clinical and non-clinical therapeuti...
November 2019
150 pages
Amyotrophic lateral sclerosis - Pipeline Review, 2019
US$ 1,250.00
Firstview Insight's Amyotrophic lateral sclerosis - Pipeline Review, 2019 provides an overview of the pipeline landscape of Amyotrophic lateral sclerosis It provides comprehensive insights of all the...
November 2019
150 pages
Anal Cancer - Pipeline Review, 2019
US$ 1,400.00
Firstview Insight's Anal Cancer - Pipeline Review, 2019 provides an overview of the pipeline landscape of Anal Cancer It provides comprehensive insights of all the clinical and non-clinical therapeuti...
November 2019
150 pages
Anaplastic Astrocytoma - Pipeline Review, 2019
US$ 1,250.00
Firstview Insight's Anaplastic Astrocytoma - Pipeline Review, 2019 provides an overview of the pipeline landscape of Anaplastic Astrocytoma It provides comprehensive insights of all the clinical and n...
November 2019
150 pages
Anaplastic Large Cell Lymphoma - Pipeline Review, 2019
US$ 1,400.00
Firstview Insight's Anaplastic Large Cell Lymphoma - Pipeline Review, 2019 provides an overview of the pipeline landscape of Anaplastic Large Cell Lymphoma It provides comprehensive insights of all th...
November 2019
150 pages
Anemia In Chronic Kidney Disease - Pipeline Review, 2019
US$ 1,250.00
Firstview Insight's Anemia In Chronic Kidney Disease - Pipeline Review, 2019 provides an overview of the pipeline landscape of Anemia In Chronic Kidney DiseaseIt provides comprehensive insights of all...
November 2019
150 pages
Angiopoietin 2 (Ang - 2) Inhibitor - Pipeline Review - 2019
US$ 1,250.00
Firstview Market Insight 'Angiopoietin 2 (Ang-2) Inhibitor - Pipeline Review-2019' provides an overview of the pipeline landscape for Angiopoietin 2 (Ang-2) Inhibitor - Pipeline Review-2019. It provid...
November 2019
58 pages
Atopic Dermatitis - Pipeline Review, 2019
US$ 1,250.00
Firstview Insight's Atopic Dermatitis - Pipeline Review, 2019 provides an overview of the pipeline landscape of Atopic DermatitisIt provides comprehensive insights of all the clinical and non-clinical...
November 2019
150 pages
Behcets Disease - Pipeline Review, 2019
US$ 1,250.00
Firstview Insight's Behcets Disease - Pipeline Review, 2019 provides an overview of the pipeline landscape of Behcets Disease It provides comprehensive insights of all the clinical and non-clinical th...
November 2019
150 pages
Beta Thalassemia - Pipeline Review, 2019
US$ 1,250.00
Firstview Insight's Beta Thalassemia - Pipeline Review, 2019 provides an overview of the pipeline landscape of Beta Thalassemia It provides comprehensive insights of all the clinical and non-clinical...
November 2019
150 pages
Bipolar Disorder - Pipeline Review, 2019
US$ 1,250.00
Firstview Insight's Bipolar Disorder - Pipeline Review, 2019 provides an overview of the pipeline landscape of Bipolar DisorderIt provides comprehensive insights of all the clinical and non-clinical t...
November 2019
150 pages
Bronchopulmonary Dysplasia - Pipeline Review, 2019
US$ 1,250.00
Firstview Insight's Bronchopulmonary Dysplasia - Pipeline Review, 2019 provides an overview of the pipeline landscape of Bronchopulmonary Dysplasia It provides comprehensive insights of all the clinic...
November 2019
150 pages
Chronic Myeloid Leukemia - Pipeline Review, 2019
US$ 1,250.00
Firstview Insight's Chronic Myeloid Leukemia - Pipeline Review, 2019 provides an overview of the pipeline landscape of Chronic Myeloid Leukemia It provides comprehensive insights of all the clinical a...
November 2019
150 pages
Colorectal cancer - Pipeline Review, 2019
US$ 1,250.00
Firstview Insight's Colorectal cancer - Pipeline Review, 2019 provides an overview of the pipeline landscape of Colorectal cancerIt provides comprehensive insights of all the clinical and non-clinical...
November 2019
150 pages
Cystic fibrosis - Pipeline Review, 2019
US$ 1,400.00
Firstview Insight's Cystic fibrosis - Pipeline Review, 2019 provides an overview of the pipeline landscape of Cystic fibrosis It provides comprehensive insights of all the clinical and non-clinical th...
November 2019
150 pages
Duchenne muscular dystrophy - Pipeline Review, 2019
US$ 1,250.00
Firstview Insight's Duchenne muscular dystrophy - Pipeline Review, 2019 provides an overview of the pipeline landscape of Duchenne muscular dystrophyIt provides comprehensive insights of all the clini...
November 2019
150 pages
Ewing Sarcoma - Pipeline Review, 2019
US$ 1,250.00
Firstview Insight's Ewing Sarcoma - Pipeline Review, 2019 provides an overview of the pipeline landscape of Ewing Sarcoma It provides comprehensive insights of all the clinical and non-clinical therap...
November 2019
150 pages
Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, 2019
US$ 1,250.00
Firstview Insight's Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, 2019 provides an overview of the pipeline landscape of Keratoconjunctivitis sicca (Dry Eye) It provides comprehensive insigh...
November 2019
120 pages
Leber Hereditary Optic Neuropathy - Pipeline Review, 2019
US$ 1,250.00
Firstview Insight's Leber Hereditary Optic Neuropathy - Pipeline Review, 2019 provides an overview of the pipeline landscape of Leber Hereditary Optic Neuropathy It provides comprehensive insights of...
November 2019
120 pages
Liver cancer - Pipeline Review, 2019
US$ 1,250.00
Firstview Insight's Liver cancer - Pipeline Review, 2019 provides an overview of the pipeline landscape of Liver cancer It provides comprehensive insights of all the clinical and non-clinical therapeu...
November 2019
120 pages
Macular Edema - Pipeline Review, 2019
US$ 1,250.00
Firstview Insight's Macular Edema - Pipeline Review, 2019 provides an overview of the pipeline landscape of Macular Edema It provides comprehensive insights of all the clinical and non-clinical therap...
November 2019
120 pages
Major depressive disorder - Pipeline Review, 2019
US$ 1,250.00
Firstview Insight's Major depressive disorder - Pipeline Review, 2019 provides an overview of the pipeline landscape of Major depressive disorderIt provides comprehensive insights of all the clinical...
November 2019
120 pages
Mantle Cell Lymphoma - Pipeline Review, 2019
US$ 1,250.00
Firstview Insight's Mantle Cell Lymphoma - Pipeline Review, 2019 provides an overview of the pipeline landscape of Mantle Cell Lymphoma It provides comprehensive insights of all the clinical and non-c...
November 2019
120 pages
Medullary Thyroid Cancer - Pipeline Review, 2019
US$ 1,250.00
Firstview Insight's Medullary Thyroid Cancer - Pipeline Review, 2019 provides an overview of the pipeline landscape of Medullary Thyroid Cancer It provides comprehensive insights of all the clinical a...
November 2019
120 pages
Medulloblastoma - Pipeline Review, 2019
US$ 1,250.00
Firstview Insight's Medulloblastoma - Pipeline Review, 2019 provides an overview of the pipeline landscape of Medulloblastoma It provides comprehensive insights of all the clinical and non-clinical th...
November 2019
120 pages
Merkel Cell Carcinoma - Pipeline Review, 2019
US$ 1,250.00
Firstview Insight's Keratoconjunctivitis sicca (Dry Eye) - Pricing and Market Access provides country specific insights in order to estimate market potential for Keratoconjunctivitis sicca (Dry Eye) b...
November 2019
120 pages
Myelodysplastic Syndrome - Pipeline Review, 2019
US$ 1,250.00
Firstview Insight's Myelodysplastic Syndrome - Pipeline Review, 2019 provides an overview of the pipeline landscape of Myelodysplastic Syndrome It provides comprehensive insights of all the clinical a...
November 2019
150 pages
Non Small cell Lung cancer(NSCLC) - Pipeline Review, 2019
US$ 1,250.00
FirstView Market Insight ' Non Small cell Lung cancer(NSCLC)- Pipeline Review, 2019' provides an overview of the pipeline landscape. It provides comprehensive insights of all the clinical and non-clin...
November 2019
182 pages
Ulcerative colitis - Pipeline Review, 2019
US$ 1,250.00
FirstView Market Insight 'Ulcerative Colitis- Pipeline Review, 2019' provides an overview of the pipeline landscape for Ulcerative Colitis- Pipeline Review, 2019. It provides comprehensive insights of...
November 2019
146 pages
